Want to join the conversation?
$ABBV 2Q15 10-Q: As of June 30, 2015, AbbVie had 1,655,276,338 shares of common stock at $0.01 par value outstanding. Total number of shares purchased in 1Q15 was 68,104,114 with average price paid per share of $66.09. AbbVie currently has a $3Bil five-year revolving credit facility, which matures in Oct. 2019.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?